Ardent Health, Inc. SEC filings ARDT

Ardent Health, Inc. has 176 filings in SEC EDGAR's recent list, going back to Oct 26, 2018. Its latest annual report, Form ARS, was filed on Apr 8, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Ardent Health, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Nov 5, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
8-K Current report
Officer or director change
Oct 23, 2026 Oct 19, 2026
4 Insider transaction Sep 29, 2026 Sep 25, 2026
4 Insider transaction Sep 29, 2026 Sep 25, 2026
4 Insider transaction Sep 29, 2026 Sep 25, 2026
8-K Current report
Other events
Sep 4, 2026 Sep 4, 2026
144 Notice of proposed sale Aug 27, 2026 —
144 Notice of proposed sale Aug 25, 2026 —
144 Notice of proposed sale Aug 20, 2026 —
144 Notice of proposed sale Aug 18, 2026 —
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 4, 2026 Aug 4, 2026
4 Insider transaction Jul 2, 2026 Jul 1, 2026
8-K Current report
Officer or director change
Jun 30, 2026 Jun 26, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
4 Insider transaction Jun 8, 2026 Jun 5, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 2, 2026 Jun 2, 2026
8-K Current report
Shareholder vote results
May 26, 2026 May 20, 2026
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
ARS Annual report to shareholders Apr 8, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 8, 2026 —
DEF 14A Proxy statement Apr 8, 2026 May 20, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Apr 1, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
4 Insider transaction Apr 2, 2026 Mar 31, 2026
8-K Current report
Officer or director change
Mar 27, 2026 Mar 24, 2026
10-K Annual report Mar 16, 2026 Dec 31, 2025
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
4 Insider transaction Mar 13, 2026 Mar 11, 2026
8-K Current report
Results of operations
Mar 4, 2026 Mar 4, 2026
8-K Current report
Regulation FD disclosure, Other events
Nov 18, 2025 Nov 17, 2025
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
4 Insider transaction Sep 30, 2025 Sep 25, 2025
4 Insider transaction Sep 30, 2025 Sep 25, 2025
4 Insider transaction Sep 30, 2025 Sep 25, 2025
8-K Current report
Material agreement, New debt
Sep 23, 2025 Sep 18, 2025
EFFECT Filing Aug 25, 2025 —
424B2 Prospectus Aug 25, 2025 —
CORRESP Letter to the SEC Aug 21, 2025 —
S-3 Shelf registration Aug 21, 2025 —
UPLOAD Letter from the SEC Aug 18, 2025 —
DRSLTR Filing Aug 13, 2025 —
DRS Filing Aug 13, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 5, 2025 Aug 5, 2025
8-K Current report
Officer or director change
Jun 20, 2025 Jun 16, 2025
8-K Current report
Bylaw or fiscal year change, Shareholder vote results
May 23, 2025 May 21, 2025
10-Q Quarterly report May 7, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 6, 2025 May 6, 2025
ARS/A Filing Apr 9, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 8, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 8, 2025 —
DEF 14A Proxy statement Apr 8, 2025 Dec 31, 2024
4 Insider transaction Apr 4, 2025 Apr 2, 2025
3 Initial insider ownership Apr 4, 2025 Apr 2, 2025
8-K Current report
Officer or director change
Apr 3, 2025 Apr 3, 2025
4 Insider transaction Apr 2, 2025 Apr 1, 2025
3 Initial insider ownership Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
8-K Current report
Officer or director change
Mar 31, 2025 Mar 31, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
4 Insider transaction Mar 25, 2025 Mar 21, 2025
10-K Annual report Feb 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Feb 26, 2025 Feb 26, 2025
8-K Current report
Results of operations, Officer or director change, Regulation FD disclosure
Jan 13, 2025 Jan 13, 2025
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 16, 2024 Dec 12, 2024
4 Insider transaction Dec 16, 2024 Dec 12, 2024
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G Ownership over 5% (passive) Nov 14, 2024 —
4 Insider transaction Nov 13, 2024 Nov 8, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 6, 2024 Nov 6, 2024
4 Insider transaction Sep 27, 2024 Sep 25, 2024
4 Insider transaction Sep 27, 2024 Sep 25, 2024
4 Insider transaction Sep 27, 2024 Sep 25, 2024
4 Insider transaction Sep 27, 2024 Sep 25, 2024
10-Q Quarterly report Aug 14, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 14, 2024 Aug 14, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
4 Insider transaction Jul 22, 2024 Jul 18, 2024
424B4 Prospectus Jul 18, 2024 —
3 Initial insider ownership Jul 18, 2024 Jul 17, 2024
SEC STAFF LETTER Filing Jul 17, 2024 —
EFFECT Filing Jul 17, 2024 —
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
3 Initial insider ownership Jul 17, 2024 Jul 17, 2024
S-8 Employee stock plan registration Jul 17, 2024 —
CERT Nyse certification Jul 16, 2024 —
8-A12B Filing Jul 16, 2024 —
CORRESP Letter to the SEC Jul 15, 2024 —
CORRESP Letter to the SEC Jul 15, 2024 —
CORRESP Letter to the SEC Jul 15, 2024 —
S-1/A Amended registration statement Jul 15, 2024 —
SEC STAFF LETTER Filing Jul 11, 2024 —
UPLOAD Letter from the SEC Jul 11, 2024 —
S-1/A Amended registration statement Jul 10, 2024 —
CORRESP Letter to the SEC Jul 8, 2024 —
S-1/A Amended registration statement Jul 8, 2024 —
UPLOAD Letter from the SEC Jun 28, 2024 —
SEC STAFF LETTER Filing Jun 27, 2024 —
CORRESP Letter to the SEC Jun 21, 2024 —
S-1 Registration statement Jun 21, 2024 —
DRSLTR Filing Jun 18, 2024 —
UPLOAD Letter from the SEC Jun 14, 2024 —
DRSLTR Filing Jun 3, 2024 —
DRS/A Filing Jun 3, 2024 —
UPLOAD Letter from the SEC May 22, 2024 —
DRSLTR Filing Apr 26, 2024 —
DRS/A Filing Apr 26, 2024 —
UPLOAD Letter from the SEC Apr 12, 2024 —
DRS Filing Mar 15, 2024 —
RW Filing Jan 8, 2020 —
S-1/A Amended registration statement Mar 6, 2019 —
S-1/A Amended registration statement Dec 21, 2018 —
S-1 Registration statement Dec 4, 2018 —
DRS Filing Oct 26, 2018 —

Showing 176 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-General Medical & Surgical Hospitals, NEC (SIC 8062)
Listed as
ARDT (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Brentwood, TN
SEC filer status
Accelerated filer
SEC CIK
1756655
Former names
Ardent Health Partners, Inc. (until May 23, 2025); Ardent Health Partners, LLC (until Jul 16, 2024)

Other Services-General Medical & Surgical Hospitals, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.